Your browser doesn't support javascript.
Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study.
Siewe Fodjo, Joseph Nelson; Ngarka, Leonard; Njamnshi, Wepnyu Y; Nfor, Leonard N; Mengnjo, Michel K; Mendo, Edwige Laure; Angwafor, Samuel A; Atchou Basseguin, Jonas Guy; Nkouonlack, Cyrille; Njit, Edith N; Ahidjo, Nene; Chokote, Eric S; Dema, Fidèle; Fonsah, Julius Y; Tatah, Godwin Y; Palmer, Nancy; Seke Etet, Paul F; Palmer, Dennis; Nsagha, Dickson S; Etya'ale, Daniel E; Perrig, Stephen; Sztajzel, Roman; Annoni, Jean-Marie; Zoung-Kanyi Bissek, Anne-Cécile; Leke, Rose G F; Abena Ondoa Obama, Marie-Thérèse; Nkengasong, John N; Colebunders, Robert; Njamnshi, Alfred K.
  • Siewe Fodjo JN; Global Health Institute, University of Antwerp, Antwerp, Belgium.
  • Ngarka L; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Njamnshi WY; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Nfor LN; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Mengnjo MK; Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
  • Mendo EL; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Angwafor SA; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Atchou Basseguin JG; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Nkouonlack C; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Njit EN; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Ahidjo N; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Chokote ES; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Dema F; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Fonsah JY; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Tatah GY; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Palmer N; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Seke Etet PF; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Palmer D; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Nsagha DS; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Etya'ale DE; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Perrig S; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Sztajzel R; Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
  • Annoni JM; Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
  • Zoung-Kanyi Bissek AC; Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
  • Leke RGF; Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
  • Abena Ondoa Obama MT; Division of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon.
  • Nkengasong JN; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Colebunders R; Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
  • Njamnshi AK; CDC Africa, African Union, Addis Ababa, Ethiopia.
BMC Psychiatry ; 21(1): 356, 2021 07 15.
Article in English | MEDLINE | ID: covidwho-1314258
ABSTRACT

BACKGROUND:

The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak.

METHODS:

An online survey was conducted in Cameroon from June-December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient Health Questionnaire (PHQ-9), respectively. Responses were clustered in weeks to better appreciate their evolution over time.

RESULTS:

Overall, 7381 responses from all ten regions of Cameroon were analysed (median age 30 years, 73.3% male). The prevalence of depression (PHQ-9 score ≥ 10) was 8.4%, and that of high fear of COVID-19 (FCV-19S scores ≥19) was 57.4%. These rates were similar across genders, age-groups, and region of residence. While mean weekly PHQ-9 scores remained fairly stable throughout the study period (range 2.53-3.21; p = 0.101), mean FCV-19S scores were highest during the early weeks but decreased significantly thereafter (from 20.31 to 18.34; p <  0.001). Multivariate analyses revealed that having a postgraduate degree, a history of quarantine, flu-like symptoms during the past 14 days, and higher FCV-19S scores were associated with more severe depressive symptoms, while obtaining COVID-19 information from various sources reduced the odds for depression.

CONCLUSION:

Depression amidst the COVID-19 crisis is less prevalent in Cameroon than in other countries. Prompt and widespread dissemination of adequate COVID-19 information may reduce the risks for depression by dispelling fear and anxiety among Cameroonians.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adult / Female / Humans / Male Country/Region as subject: Africa Language: English Journal: BMC Psychiatry Journal subject: Psychiatry Year: 2021 Document Type: Article Affiliation country: S12888-021-03323-X

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adult / Female / Humans / Male Country/Region as subject: Africa Language: English Journal: BMC Psychiatry Journal subject: Psychiatry Year: 2021 Document Type: Article Affiliation country: S12888-021-03323-X